Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
January-2020 Volume 43 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2020 Volume 43 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity

  • Authors:
    • Jagoda Mierzejewska
    • Agnieszka Szczygieł
    • Natalia Anger‑Góra
    • Joanna Rossowska
    • Joanna Jarosz
    • Joanna Wietrzyk
    • Marta Kaszowska
    • Anna Maciejewska
    • Wojciech Jachymek
    • Tomasz Niedziela
    • Jolanta Lukasiewicz
    • Czesław Lugowski
    • Janusz Boratyński
    • Elżbieta Pajtasz‑Piasecka
  • View Affiliations / Copyright

    Affiliations: Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53‑114 Wroclaw, Poland
  • Pages: 270-281
    |
    Published online on: November 8, 2019
       https://doi.org/10.3892/or.2019.7403
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lipopolysaccharides are the main surface antigens and virulence factors of gram‑negative bacteria. Removal of four ester‑bound fatty acid residues from hexaacyl lipid A of Escherichia coli lipooligosaccharide (LOS) resulted in the de‑O‑acylated derivative E. coli LOS‑OH (LOS‑OH). This procedure caused a significant reduction in the toxicity of this compound compared to the native molecule. We investigated the effect of such a structural LOS modification on its biological activity using in vitro assays with monocytic cells of the RAW264.7 line, dendritic cells of the JAWS II line, bone marrow‑derived dendritic cells (BM‑DCs), and spleen cells. Furthermore, in in vivo experiments with a melanoma B16 metastasis model, the anti‑metastatic activity of the compounds and spleen cell reactivity mediated by them representing a systemic response were analyzed. The results revealed that LOS‑OH demonstrated weaker ability than LOS to stimulate and polarize an immune response both in vitro and in vivo. It induced lower cytokine production by cells of myeloid lines. Multiple applications of LOS‑OH into mice injected intravenously with B16 cells significantly (P<0.05; P<0.01) reduced the number of metastatic foci in the lungs, presumably via silencing of myeloid cell reactivity as well as the inability to stimulate lymphoid cells both directly and indirectly. These findings suggest that LOS‑OH maintained in the body of metastasis‑bearing mice appears to modulate or downregulate the innate response, leading to the inability of blood myeloid cells to support the migration of melanoma cells to lung tissue.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Lien E, Heine H and Golenbock DT: LPS receptorsImmune Response in the Critically Ill. Marshall JC and Cohen J: Springer Berlin Heidelberg; Berlin, Heidelberg: pp. 164–172. 2002, https://doi.org/10.1007/978-3-642-57210-4_11 View Article : Google Scholar

2 

Raetz CR and Whitfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem. 71:635–700. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Lundin JI and Checkoway H: Endotoxin and cancer. Environ Health Perspect. 117:1344–1350. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Puntoni M, Marra D, Zanardi S and Decensi A: Inflammation and cancer prevention. Ann Oncol. 19 (Suppl 7):vii225–vii229. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Schottenfeld D and Beebe-Dimmer J: Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 56:69–83. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Caroff M and Karibian D: Structure of bacterial lipopolysaccharides. Carbohydr Res. 338:2431–2447. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Caroff M, Karibian D, Cavaillon JM and Haeffner-Cavaillon N: Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect. 4:915–926. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Kicielińska J, Szczygieł A, Rossowska J, Anger N, Kempińska K, Świtalska M, Kaszowska M, Wietrzyk J, Boratyński J and Pajtasz-Piasecka E: Oral administration of Polymyxin B modulates the activity of lipooligosaccharide E. coli B against lung metastases in murine tumor models. PLoS One. 11:e01481562016. View Article : Google Scholar : PubMed/NCBI

9 

Kaszowska M, Niedziela T, Maciejewska A, Lukasiewicz J, Jachymek W and Lugowski C: Core oligosaccharide of Escherichia coli B-the structure required for bacteriophage T4 recognition. Carbohydr Res. 413:51–54. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Lukasiewicz J, Jachymek W, Niedziela T, Malik-Gebicka M, Dzieciatkowska M and Lugowski C: Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate. Acta Biochim Pol. 49:721–734. 2002.PubMed/NCBI

11 

Holst O: Deacylation of lipopolysaccharides and isolation of oligosaccharide phosphates. Methods Mol Biol. 145:345–353. 2000.PubMed/NCBI

12 

Sturiale L, Palmigiano A, Silipo A, Knirel YA, Anisimov AP, Lanzetta R, Parrilli M, Molinaro A and Garozzo D: Reflectron MALDI TOF and MALDI TOF/TOF mass spectrometry reveal novel structural details of native lipooligosaccharides. J Mass Spectrom. 46:1135–1142. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Rossowska J, Pajtasz-Piasecka E, Szyda A, Krawczenko A, Zietara N and Dus D: Tumour antigen-loaded mouse dendritic cells maturing in the presence of inflammatory cytokines are potent activators of immune response in vitro but not in vivo. Oncol Rep. 21:1539–1549. 2009.PubMed/NCBI

14 

Rossowska J, Pajtasz-Piasecka E, Anger N, Wojas-Turek J, Kicielińska J, Piasecki E and Duś D: Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs number. J Immunother. 37:427–439. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Mohanty S and Xu L: Experimental metastasis assay. J Vis Exp:. (pii): 19422010.doi: 10.3791/1942. PubMed/NCBI

16 

Korneev KV, Kondakova AN, Arbatsky NP, Novototskaya-Vlasova KA, Rivkina EM, Anisimov AP, Kruglov AA, Kuprash DV, Nedospasov SA, Knirel YA and Drutskaya MS: Distinct biological activity of lipopolysaccharides with different lipid A acylation status from mutant strains of Yersinia pestis and some members of genus Psychrobacter. Biochemistry (Mosc). 79:1333–1338. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Górska S, Sandstrőm C, Wojas-Turek J, Rossowska J, Pajtasz-Piasecka E, Brzozowska E and Gamian A: Structural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel disease. Sci Rep. 6:376132016. View Article : Google Scholar : PubMed/NCBI

18 

Miernikiewicz P, Dąbrowska K, Piotrowicz A, Owczarek B, Wojas-Turek J, Kicielińska J, Rossowska J, Pajtasz-Piasecka E, Hodyra K, Macegoniuk K, et al: T4 phage and its head surface proteins do not stimulate inflammatory mediator production. PLoS One. 8:e710362013. View Article : Google Scholar : PubMed/NCBI

19 

Szczygieł A and Pajtasz-Piasecka E: Between biology and medicine: Perspectives on the use of dendritic cells in anticancer therapy. Postepy Hig Med Dosw (Online). 71:921–941. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Maeshima N and Fernandez RC: Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol. 3:32013. View Article : Google Scholar : PubMed/NCBI

21 

Cross AS: Endotoxin tolerance-current concepts in historical perspective. J Endotoxin Res. 8:83–98. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Gioannini TL, Teghanemt A, Zarember KA and Weiss JP: Regulation of interactions of endotoxin with host cells. J Endotoxin Res. 9:401–408. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Mackensen A, Galanos C, Wehr U and Engelhardt R: Endotoxin tolerance: Regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw. 3:571–579. 1992.PubMed/NCBI

24 

Rockwell CE, Morrison DC and Qureshi N: Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol. 667:81–99. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Ruggiero V, D'Urso CM, Albertoni C, Campo S, Foresta P and Martelli EA: LPS-induced serum TNF production and lethality in mice: Effect of L-carnitine and some acyl-derivatives. Mediators Inflamm. 2 (Suppl):S43–S50. 1993. View Article : Google Scholar : PubMed/NCBI

26 

Munford RS and Hall CL: Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science. 234:203–205. 1986. View Article : Google Scholar : PubMed/NCBI

27 

Nielsen SR and Schmid MC: Macrophages as key drivers of cancer progression and metastasis. Mediators Inflamm. 2017:96247602017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mierzejewska J, Szczygieł A, Anger‑Góra N, Rossowska J, Jarosz J, Wietrzyk J, Kaszowska M, Maciejewska A, Jachymek W, Niedziela T, Niedziela T, et al: De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity. Oncol Rep 43: 270-281, 2020.
APA
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J. ... Pajtasz‑Piasecka, E. (2020). De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity. Oncology Reports, 43, 270-281. https://doi.org/10.3892/or.2019.7403
MLA
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J., Kaszowska, M., Maciejewska, A., Jachymek, W., Niedziela, T., Lukasiewicz, J., Lugowski, C., Boratyński, J., Pajtasz‑Piasecka, E."De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity". Oncology Reports 43.1 (2020): 270-281.
Chicago
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J., Kaszowska, M., Maciejewska, A., Jachymek, W., Niedziela, T., Lukasiewicz, J., Lugowski, C., Boratyński, J., Pajtasz‑Piasecka, E."De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity". Oncology Reports 43, no. 1 (2020): 270-281. https://doi.org/10.3892/or.2019.7403
Copy and paste a formatted citation
x
Spandidos Publications style
Mierzejewska J, Szczygieł A, Anger‑Góra N, Rossowska J, Jarosz J, Wietrzyk J, Kaszowska M, Maciejewska A, Jachymek W, Niedziela T, Niedziela T, et al: De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity. Oncol Rep 43: 270-281, 2020.
APA
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J. ... Pajtasz‑Piasecka, E. (2020). De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity. Oncology Reports, 43, 270-281. https://doi.org/10.3892/or.2019.7403
MLA
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J., Kaszowska, M., Maciejewska, A., Jachymek, W., Niedziela, T., Lukasiewicz, J., Lugowski, C., Boratyński, J., Pajtasz‑Piasecka, E."De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity". Oncology Reports 43.1 (2020): 270-281.
Chicago
Mierzejewska, J., Szczygieł, A., Anger‑Góra, N., Rossowska, J., Jarosz, J., Wietrzyk, J., Kaszowska, M., Maciejewska, A., Jachymek, W., Niedziela, T., Lukasiewicz, J., Lugowski, C., Boratyński, J., Pajtasz‑Piasecka, E."De‑O‑acylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity". Oncology Reports 43, no. 1 (2020): 270-281. https://doi.org/10.3892/or.2019.7403
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team